Brief: Hin Sang Group (International) Says Unit Entered Into Cooperation Agreement With Hongli Homologous Biotechnology

Hin Sang (International) Holding

29/12/2021 14:14

Dec 29 (Reuters) - Hin Sang Group (International) Holding Co
Ltd  6893.HK :
    * UNIT ENTERED INTO A COOPERATION AGREEMENT WITH HONGLI
HOMOLOGOUS
BIOTECHNOLOGY
    * AGREEMENT TO ESTABLISH PENGZU HIN SANG PAVILION
(GUANGDONG)
BRAND MANAGEMENT CO
    * REGISTERED SHARE CAPITAL OF NEW CO RMB10 MILLION

Source text for Eikon:  ID:nHKS36K4sy 
Further company coverage:  6893.HK 

 ((Reuters.Briefs@thomsonreuters.com;))